Effect of diabetes on transscleral delivery of celecoxib

Pharmaceutical Research

Volumn 26, Issue 2, 2009, Pages 404-414

  Cheruvu, Narayan P S ^a,c   Amrite, Aniruddha C ^a,d   Kompella, Uday B ^a,b  

^a UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Covidien Ltd ^*  (United States)

^d IQVIA   (United States)

Author keywords

Blood retinal barrier; Diabetes; Periocular injection; Pigmentation; Transscleral

Indexed keywords

CELECOXIB; DEXTRAN; FLUORESCEIN ISOTHIOCYANATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN NORWAY RAT; CONTROLLED STUDY; CORNEA; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LENS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SCLERA; SPRAGUE DAWLEY RAT; STRAIN DIFFERENCE; STREPTOZOCIN DIABETES;

ANIMALS; AREA UNDER CURVE; BLOOD GLUCOSE; BLOOD-RETINAL BARRIER; BODY WEIGHT; CAPILLARY PERMEABILITY; CORNEA; CYCLOOXYGENASE INHIBITORS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; LENS, CRYSTALLINE; MALE; PYRAZOLES; RATS; RATS, INBRED BN; RATS, SPRAGUE-DAWLEY; SCLERA; SPECIES SPECIFICITY; SULFONAMIDES; VITREOUS BODY;

EID: 58549103376     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-008-9757-2     Document Type: Article

References (62)

1. S. In 2004 Causes and prevalence of visual impairment among adults in the United States Am. Med. Assoc. 122 477 485
2. M. V. Emerson A. K. Lauer 2007 Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema BioDrugs 21 245 257
3. D. J. D'Amico M. F. Goldberg H. Hudson J. A. Jerdan D. S. Krueger S. P. Luna S. M. Robertson S. Russell L. Singerman J. S. Slakter L. Yannuzzi P. Zilliox 2003 Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes Ophthalmology 110 2372 2383 discussion 2384-2385
4. U. B. Kompella N. Bandi S. P. Ayalasomayajula 2003 Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression Invest. Ophthalmol. Vis. Sci. 44 1192 1201
5. S. P. Ayalasomayajula U. B. Kompella 2003 Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model Eur. J Pharmacol. 458 283 289
6. S. P. Ayalasomayajula U. B. Kompella 2005 Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model Eur. J. Pharmacol. 511 191 198
7. J. Y. Tsui C. Dalgard K. R. Van Quill L. Lee H. E. Grossniklaus H. F. Edelhauser J. M. O'Brien 2008 Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma Invest. Ophthalmol. Vis. Sci. 49 490 496
8. J. Ambati E. S. Gragoudas J. W. Miller T. T. You K. Miyamoto F. C. Delori A. P. Adamis 2000 Transscleral delivery of bioactive protein to the choroid and retina Invest. Ophthalmol. Vis. Sci. 41 1186 1191
9. J. Ambati A. P. Adamis 2002 Transscleral drug delivery to the retina and choroid Prog. Retin. Eye Res. 21 145 151
10. I. Ahmed T. F. Patton 1985 Importance of the noncorneal absorption route in topical ophthalmic drug delivery Invest. Ophthalmol. Vis. Sci. 26 584 587
11. J. Ambati C. S. Canakis J. W. Miller E. S. Gragoudas A. Edwards D. J. Weissgold I. Kim F. C. Delori A. P. Adamis 2000 Diffusion of high molecular weight compounds through sclera Invest. Ophthalmol. Vis. Sci. 41 1181 1185
12. T. W. Olsen H. F. Edelhauser J. I. Lim D. H. Geroski 1995 Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning Invest. Ophthalmol. Vis. Sci. 36 1893 1903
13. D. E. Rudnick J. S. Noonan D. H. Geroski M. R. Prausnitz H. F. Edelhauser 1999 The effect of intraocular pressure on human and rabbit scleral permeability Invest. Ophthalmol. Vis. Sci. 40 3054 3058
14. T. W. Olsen S. Y. Aaberg D. H. Geroski H. F. Edelhauser 1998 Human sclera: thickness and surface area Am. J. Ophthalmol. 125 237 241
15. S. B. Lee D. H. Geroski M. R. Prausnitz H. F. Edelhauser 2004 Drug delivery through the sclera: effects of thickness, hydration, and sustained release systems Exp. Eye Res. 78 599 607
16. M. R. Robinson S. S. Lee H. Kim S. Kim R. J. Lutz C. Galban P. M. Bungay P. Yuan N. S. Wang J. Kim K. G. Csaky 2006 A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide Exp. Eye Res. 82 479 487
17. L. Pitkanen V. P. Ranta H. Moilanen A. Urtti 2005 Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity Invest. Ophthalmol. Vis. Sci. 46 641 646
18. N. P. Cheruvu U. B. Kompella 2006 Bovine and porcine transscleral solute transport: influence of lipophilicity and the Choroid-Bruch's layer Invest. Ophthalmol. Vis. Sci. 47 4513 4522
19. N. P. Cheruvu A. C. Amrite U. B. Kompella 2008 Effect of eye pigmentation on transscleral drug delivery Invest. Ophthalmol. Vis. Sci. 49 333 341
20. A. C. Amrite H. F. Edelhauser U. B. Kompella 2008 Modeling of corneal and retinal pharmacokinetics after periocular drug administration Invest. Ophthalmol. Vis. Sci. 49 320 332
21. F. Ozturk S. Kortunay E. Kurt S. S. Ilker N. E. Basci A. Bozkurt 1999 Penetration of topical and oral ciprofloxacin into the aqueous and vitreous humor in inflamed eyes Retina 19 218 222
22. F. Ozturk S. Kortunay E. Kurt S. S. Ilker U. U. Inan N. E. Basci A. Bozkurt O. Kayaalp 1999 Effects of trauma and infection on ciprofloxacin levels in the vitreous cavity Retina 19 127 130
23. F. Ozturk S. Kortunay E. Kurt U. U. Inan S. S. Ilker N. Basci A. Bozkurt 1999 The effect of long-term use and inflammation on the ocular penetration of topical ofloxacin Curr. Eye Res. 19 461 464
24. F. Ozturk S. Kortunay E. Kurt U. Ubeyt Inan S. Sami Ilker N. E. Basci A. Bozkurt S. Oguz Kayaalp 1999 Ofloxacin levels after intravitreal injection. Effects of trauma and inflammation Ophthalmic. Res. 31 446 451
25. F. Ozturk E. Kurt U. U. Inan M. C. Kortunay S. S. Ilker N. E. Basci A. Bozkurt 2000 Penetration of topical and oral ofloxacin into the aqueous and vitreous humor of inflamed rabbit eyes Int. J. Pharm. 204 91 95
26. F. Ozturk E. Kurt U. U. Inan S. Kortunay S. S. Ilker N. E. Basci A. Bozkurt 2000 The effects of prolonged acute use and inflammation on the ocular penetration of topical ciprofloxacin Int. J. Pharm. 204 97 100
27. R. Yagci Y. Oflu A. Dincel E. Kaya S. Yagci B. Bayar S. Duman A. Bozkurt 2007 Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model Eye 21 990 994
28. N. P. Blair M. O. Tso J. T. Dodge 1984 Pathologic studies of the blood-retinal barrier in the spontaneously diabetic BB rat Invest. Ophthalmol. Vis. Sci. 25 302 311
29. S. X. Zhang J. X. Ma J. Sima Y. Chen M. S. Hu A. Ottlecz G. N. Lambrou 2005 Genetic difference in susceptibility to the blood-retina barrier breakdown in diabetes and oxygen-induced retinopathy Am. J. Pathol. 166 313 321
30. A. C. Amrite U. B. Kompella 2008 Celecoxib inhibits proliferation of retinal pigment epithelial and choroid-retinal endothelial cells by a cyclooxygenase-2-independent mechanism J. Pharmacol. Exp. Ther. 324 749 758
31. L. De Schaepdrijver P. Simoens H. Lauwers J. P. De Geest 1989 Retinal vascular patterns in domestic animals Res. Vet. Sci. 47 34 42
32. Z. Dagher Y. S. Park V. Asnaghi T. Hoehn C. Gerhardinger M. Lorenzi 2004 Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy Diabetes 53 2404 2411
33. J. A. De Juan F. J. Moya A. Ripodas R. Bernal A. Fernandez-Cruz R. Fernandez-Durango 2000 Changes in the density and localisation of endothelin receptors in the early stages of rat diabetic retinopathy and the effect of insulin treatment Diabetologia 43 773 785
34. A. De Roetth Jr. F. P. Yen 1960 Experimental diabetic retinopathy. Retinal metabolism in the alloxan diabetic rat Arch. Ophthalmol. 63 226 231
35. E. A. Ellis D. L. Guberski B. Hutson M. B. Grant 2002 Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat Nitric Oxide 6 295 304
36. G. G. Quin A. C. Len F. A. Billson M. C. Gillies 2007 Proteome map of normal rat retina and comparison with the proteome of diabetic rat retina: new insight in the pathogenesis of diabetic retinopathy Proteomics 7 2636 2650
37. W. G. Robison Jr 1995 Diabetic retinopathy: galactose-fed rat model Invest. Ophthalmol. Vis. Sci. 36 (4A), 1743 1744
38. R. Rollin A. Mediero A. Fernandez-Cruz R. Fernandez-Durango 2005 Downregulation of the atrial natriuretic peptide/natriuretic peptide receptor-C system in the early stages of diabetic retinopathy in the rat Mol. Vis. 11 216 224
39. E. Rungger-Brandle A. A. Dosso 2003 Streptozotocin-induced diabetes-a rat model to study involvement of retinal cell types in the onset of diabetic retinopathy Adv. Exp. Med. Biol. 533 197 203
40. Z. Zheng H. Chen X. Xu C. Li Q. Gu 2007 Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy Exp. Eye Res. 84 745 752
41. A. C. Amrite S. P. Ayalasomayajula N. P. Cheruvu U. B. Kompella 2006 Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage Invest. Ophthalmol. Vis. Sci. 47 1149 1160
42. S. P. Ayalasomayajula A. C. Amrite U. B. Kompella 2004 Inhibition of cyclooxygenase-2, but not cyclooxygenase-1, reduces prostaglandin E2 secretion from diabetic rat retinas Eur. J. Pharmacol. 498 275 278
43. S. P. Ayalasomayajula U. B. Kompella 2002 Induction of vascular endothelial growth factor by 4-hydroxynonenal and its prevention by glutathione precursors in retinal pigment epithelial cells Eur. J. Pharmacol. 449 213 220
44. S. Ishida T. Usui K. Yamashiro Y. Kaji E. Ahmed K. G. Carrasquillo S. Amano T. Hida Y. Oguchi A. P. Adamis 2003 VEGF164 is proinflammatory in the diabetic retina Invest. Ophthalmol. Vis. Sci. 44 2155 2162
45. S. P. Ayalasomayajula U. B. Kompella 2004 Retinal delivery of celecoxib is several-fold higher following subconjunctival administration compared to systemic administration Pharm. Res. 21 1797 1804
46. O. Weijtens E. J. Feron R. C. Schoemaker A. F. Cohen E. G. Lentjes F. P. Romijn J. C. van Meurs 1999 High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection Am. J. Ophthalmol. 128 192 197
47. D. Ghate W. Brooks B. E. McCarey H. F. Edelhauser 2007 Pharmacokinetics of intraocular drug delivery by periocular injections using ocular fluorophotometry Invest. Ophthalmol. Vis. Sci. 48 2230 2237
48. T. Ishibashi K. Tanaka Y. Taniguchi 1980 Disruption of blood-retinal barrier in experimental diabetic rats: an electron microscopic study Exp. Eye Res. 30 401 410
49. M. O. Tso J. G. Cunha-Vaz C. Y. Shih C. W. Jones 1980 Clinicopathologic study of blood-retinal barrier in experimental diabetes mellitus Arch. Ophthalmol. 98 2032 2040
50. I. H. Wallow 1983 Posterior and anterior permeability defects? Morphologic observations on streptozotocin-treated rats Invest. Ophthalmol. Vis. Sci. 24 1259 1268
51. A. Do carmo P. Ramos A. Reis R. Proenca J. G. Cunha-vaz 1998 Breakdown of the inner and outer blood retinal barrier in streptozotocin-induced diabetes Exp. Eye Res. 67 569 575
52. W. M. Kirber C. W. Nichols P. A. Grimes A. I. Winegrad A. M. Laties 1980 A permeability defect of the retinal pigment epithelium. Occurrence in early streptozocin diabetes Arch. Ophthalmol. 98 725 728
53. S. A. Vinores P. A. Campochiaro B. P. Conway 1990 Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes Invest. Ophthalmol. Vis. Sci. 31 14 28
54. S. A. Vinores P. A. Campochiaro A. Lee R. McGehee C. Gadegbeku W. R. Green 1990 Localization of blood-retinal barrier breakdown in human pathologic specimens by immunohistochemical staining for albumin Lab. Invest. 62 742 750
55. S. A. Vinores P. A. Campochiaro R. McGehee W. Orman S. F. Hackett L. M. Hjelmeland 1990 Ultrastructural and immunocytochemical changes in retinal pigment epithelium, retinal glia, and fibroblasts in vitreous culture Invest. Ophthalmol. Vis. Sci. 31 2529 2545
56. S. A. Vinores R. McGehee A. Lee C. Gadegbeku P. A. Campochiaro 1990 Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats J. Histochem. Cytochem. 38 1341 1352
57. R. B. Caldwell B. J. McLaughlin 1985 Freeze-fracture study of filipin binding in photoreceptor outer segments and pigment epithelium of dystrophic and normal retinas J. Comp. Neurol. 236 523 537
58. R. B. Caldwell S. M. Slapnick B. J. McLaughlin 1985 Lanthanum and freeze-fracture studies of retinal pigment epithelial cell junctions in the streptozotocin diabetic rat Curr. Eye Res. 4 215 227
59. A. W. Stitt T. Bhaduri C. B. T. McMullen T. A. Gardiner D. B. Archer 2000 Advanced glycation end products induce blood-retinal barrier dysfunction in normoglycemic rats Molec. Cell Biol. Res. Commun. 3 380 388
60. J. I. Gallin, I. M. Goldstein, and R. Snyderman. Inflammation: basic principles and clinical correlates. Raven Press, New York, N. Y, 1992.
61. A. Garner 1993 Histopathology of diabetic retinopathy in man Eye 7 Pt 2 250 253
62. K. Miyamoto Y. Ogura 1999 Pathogenetic potential of leukocytes in diabetic retinopathy Semin. Ophthalmol. 14 233 239